Scientists have leveraged artificial intelligence to develop a new bird flu vaccine that reportedly outperforms currently stockpiled shots. According to reports from Medical Xpress published in November 2026, this innovative application of AI aims to improve upon existing vaccine technologies used for bird flu preparedness. While specific technical metrics and institutional details remain limited in the initial announcement, the development highlights the growing role of artificial intelligence in medical research, vaccine design, and the enhancement of global pandemic response capabilities.